Search Results 21-30 of 14444 for Assay
Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol · Overview · Participation eligibility · Participating Mayo Clinic ...
Strong development team for validation of novel assays and improvement of current assay methodology. Automated chemistry and immunoassay analyzers, liquid ...
CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung (DELFI-L201). Print details. Share; Facebook · Twitter. Overview ...
Novel MOG assay aids diagnosis of demyelinating diseases · Mayo Clinic has developed the first test available in the US to identify the myelin oligodendrocyte ...
The objectives of this protocol are to develop and validate clinical assays for inborn errors of metabolism (IEMs) using specimens collected from consenting ...
To evaluate the ability of the plasma MDM assay to predict CRC recurrence when tested serially following curative resection of CRC metastases. Participation ...
... assay for the detection of mutations associated with uveal melanoma. The performance characteristics of the ddPCR assay for the detection of ctDNA mutation ...
If the test is available on an existing platform in the Targeted Biomarker Core, the core can perform the assay if the number of samples is sufficient and with ...
The objective of this study is to validate internally developed assays for the detection of clinically relevant gene mutations in cfDNA from the peripheral ...
... assay methods. To further examine FC's potential as a biomarker for disease activity in UC, Dr. Loftus and colleagues conducted a retrospective observation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.